[Lupus nephritis: treatments for today and tomorrow].
de Frutos
M A
MA
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D023201:CD40 Ligand / Q000276:immunology; D017338:Cladribine / Q000627:therapeutic use; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005544:Forecasting; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D008181:Lupus Nephritis / Q000188:drug therapy / Q000628:therapy*; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D009841:Oligonucleotides / Q000627:therapeutic use; D010956:Plasmapheresis; D014740:Vidarabine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D009841:Oligonucleotides; D023201:CD40 Ligand; D017338:Cladribine; D014740:Vidarabine; D009173:Mycophenolic Acid; C024352:fludarabine; C094104:abetimus